) Reports on Acquisition or Disposition of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31
of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31/12/20) 2019 (01/01/19 -31/12/19
of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31/12/20) 2019 (01/01/19 -31/12/19
Acquisition or Disposition of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31/12/20) 2019
Offer List of management who submitted the changes in securities holding report (59-2) Reports on Acquisition or Disposition of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version
submitted the changes in securities holding report (59-2) Reports on Acquisition or Disposition of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income
trademark “Wuttisak Clinic”. 3. Analysis of Operating Results Profit & Loss Statements (MB) Consolidated Financial Statements 2017 2016 +/(-) % Revenues from sales and services . . . . % Gross profit from
and its Subsidiary (together referred to as “Corporate Group”) would like to clarify on the operating results according to the consolidated financial statements of Year 2018 for the year ended December
Subsidiary (together referred to as “Corporate Group”) would like to clarify on the operating results according to the consolidated financial statements of Year 2019 for the year ended December 31, 2019 as
Subsidiary (together referred to as “Corporate Group”) would like to clarify on the operating results according to the consolidated financial statements of Year 2017 for the year ended December 31, 2017 as